Nuvation Bio Inc. (NUVB)
NYSE·Healthcare·Biotechnology
$6.45
+4.55%
Mkt Cap $2.32B
Analyst Ratings
Buy
12
Hold
1
Sell
0
Price Target (18 analysts)
$16.00
Range $13.00 – $19.00
Implied Upside
+148.3%
Consensus $16.00 vs current $6.45
NYSE·Healthcare·Biotechnology
$6.45
+4.55%
Mkt Cap $2.32B
Buy
12
Hold
1
Sell
0
Price Target (18 analysts)
$16.00
Range $13.00 – $19.00
+148.3%
Consensus $16.00 vs current $6.45